Regimens for nontuberculous mycobacterial lung disease lack early bactericidal activity.

women with breast cancer. Oncologist 2014; 19: 1216–1226. 8 Katayama N, Sato S, Katsui K, et al. Analysis of factors associated with radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy. Int J Radiat Oncol Biol Phys 2009; 73: 1049–1054. 9 Bhatt JM, Bush A, van Gerven M, et al. A statement on the multidisciplinary respiratory management of ataxia telangiectasia. Eur Respir Rev 2015; 24: 565–581. 10 Bhatt JM, Bush A, van Gerven M, et al. Ataxia telangiectasia: why should the ERS care? Eur Respir J 2015; 46: 1557–1560. 11 Schroeder SA, Swift M, Sandoval C, et al. Interstitial lung disease in patients with ataxia-telangiectasia. Pediatr Pulmonol 2005; 39: 537–543. 12 Zhang L, Yang M, Bi N, et al. ATM polymorphisms are associated with risk of radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 2010; 77: 1360–1368. 13 Ostendorf BN, Terwey TH, Hemmati PG, et al. Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutation. Eur J Haematol 2015; 95: 90–92. 14 Renwick A, Thompson D, Seal S, et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 2006; 38: 873–875.